Position in BBIO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$70,636,112
+$32,518,927 QoQ
Shares Held
951,200
+90.9% QoQ
Ownership
0.486%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Clearbridge Investments, LLC holds $2,718,012,251 across 26 Biotechnology names. BBIO ranks #6 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,700,975 | $1,206,093,376 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,356,036 | $448,671,631 | |
| 3 | ARGX |
Argenx SE
|
231,356 | $168,947,719 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
3,210,930 | $106,667,094 | |
| 5 | INSM |
INSMED Inc
|
643,435 | $105,214,491 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
This page
|
951,200 | $70,636,112 | |
| 7 | PTGX |
Protagonist Therapeutics, Inc
|
621,820 | $65,539,828 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
671,870 | $62,067,350 |
All Filings in BBIO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $70,636,112 | 951,200 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $38,117,185 | 498,329 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $25,609,692 | 493,063 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,978,239 | 184,767 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||